🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Start Date
2007-05
Trial ID
NCT00467740
Treatments Being Tested
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT02259959
The primary objective of this study is to assess the long-term efficacy and...
Status
Completed
Location
1222.14.5004 Boehringer Ingelheim Investigational Site
Start Date
2009-01
Trial ID
NCT00796653
Treatments Being Tested
Study to investigate safety and tolerability of single, inhaled doses (2.5 ...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02259946
Treatments Being Tested
To investigate safety, tolerability, and pharmacokinetics (PK) of single i....
Status
Terminated
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT02172131
Treatments Being Tested
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.25.25009 Boehringer Ingelheim Investigational Site
Start Date
2009-06
Trial ID
NCT00932646
Treatments Being Tested
Study to evaluate safety, tolerability, and pharmacokinetics of BI 1744 CL ...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02172105
Treatments Being Tested
The study is intended to characterize the lung function profile of BI1744 i...
Status
Completed
Location
1222.39.32003 Boehringer Ingelheim Investigational Site
Start Date
2010-01
Trial ID
NCT01040689
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT02171806
Treatments Being Tested
Study to investigate safety, tolerability, and pharmacokinetics of single r...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT02171793
Treatments Being Tested